Karmiris Efthymios, Chalkiadaki Evangelia, Papakonstantinou Evangelia, Georgalas Ilias
Department of Ophthalmology, 251 Hellenic Airforce General Hospital, Athens, Greece.
First Department of Ophthalmology, National and Kapodistrian University of Athens, General Hospital "G. Gennimatas", Athens, Greece.
Saudi J Ophthalmol. 2022 Aug 29;36(2):207-212. doi: 10.4103/sjopt.sjopt_28_21. eCollection 2022 Apr-Jun.
To evaluate the long-term visual function and patient satisfaction in patients implanted bilaterally with the same type of multifocal intraocular lens (MIOL), using either a 2.2 mm small corneal incision with bimanual irrigation/aspiration (I/A) or a conventional 2.75 mm incision with coaxial I/A.
Prospective nonrandomized study including 100 eyes of 50 patients who underwent bilateral implantation of ReSTOR SN6AD1 through a 2.2 mm or 2.75 mm corneal incision. Outcomes included visual function measures (near, intermediate, and distance visual acuity [VA]), achievement of targeted refraction and postoperative astigmatism. Patient satisfaction was evaluated using a subjective questionnaire.
Three and 12 months postoperatively, distance uncorrected best VA (UBVA) was 0.98 ± 0.07, UBVA at 30 cm was J1 in 100% of cases and UBVA at 60 cm was J3 in 72% of cases. Targeted refraction was achieved in 84% of cases and postoperative astigmatism was -0.4 ± 0.3 diopters. There was no statistically significant difference in UBVA in all distances, targeted refraction and postoperative astigmatism between the small-incision bimanual and the conventional coaxial group. Sixty percent of the patients were satisfied, 30% were very satisfied and 10% declared that the result did not meet their expectations. Three out of 5 nonsatisfied patients had an angle kappa of 4° and the MIOL was not well-centered.
An incision size of 2.2 mm compared to 2.75 mm, did not appear to result in less surgically induced astigmatism after the implantation of a MIOL. SN6AD1 is a reliable MIOL choice for spectacle independence. Good preoperative patient selection is of crucial importance for the outcome in MIOLs.
评估采用2.2毫米小角膜切口双手操作灌注/抽吸术(I/A)或传统2.75毫米切口同轴I/A术式,双侧植入同类型多焦点人工晶状体(MIOL)患者的长期视觉功能和患者满意度。
前瞻性非随机研究,纳入50例患者的100只眼,这些患者通过2.2毫米或2.75毫米角膜切口双侧植入ReSTOR SN6AD1。观察指标包括视觉功能测量(近视力、中视力和远视力[VA])、目标屈光度的达成情况以及术后散光。采用主观问卷评估患者满意度。
术后3个月和12个月时,远距未矫正最佳视力(UBVA)为0.98±0.07,30厘米处的UBVA在100%的病例中为J1,60厘米处的UBVA在72%的病例中为J3。84%的病例实现了目标屈光度,术后散光为-0.4±0.3屈光度。小切口双手操作组和传统同轴组在所有距离的UBVA、目标屈光度和术后散光方面无统计学显著差异。60%的患者满意,30%的患者非常满意,10%的患者表示结果未达预期。5例不满意患者中有3例的房角κ值为4°,且MIOL未很好居中。
与2.75毫米相比,2.2毫米的切口大小在植入MIOL后似乎并未导致更少的手术源性散光。SN6AD1是实现脱镜的可靠MIOL选择。良好的术前患者选择对MIOL手术效果至关重要。